Lior Carmon in

Lior Carmon

Login to view DISC.
Co-Founder and CSO at Imyun Pharmaceuticals
📍 Tel Aviv-Yafo, Tel Aviv District, Israel

Lior is an immunologist and biopharma executive with over 25 years of experience translating scientific innovation into commercial success. He is the owner of Biopharma Investment and Management, a consultancy and CRO focused on immunology. A serial entrepreneur, he has co-founded multiple biotech companies, including Imyun and BIoKine Therapeutics. People who have worked with him describe him as creative, innovative, and enthusiastic.

Lior demonstrates a deep intellectual curiosity for the mechanisms behind complex diseases, often sharing and commenting on new research in neuroinflammation, oncology, and immune system function. His focus is on bridging the gap between scientific discovery and real-world application, driven by a passion for advancing therapeutic concepts into clinical development.

Unique fact: He co-founded BIoKine Therapeutics after completing his PhD in immunology at the prestigious Weizmann Institute of Science.

Read the full overview →
Experience
26 Years
Current Role
Co-Founder and CSO
Job Level
Leadership
Location
Tel Aviv-Yafo, Tel Aviv District, Israel
Personality Overview

How Lior shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Lior cares about

Immunotherapy Innovation
His career focuses on developing novel immunotherapies, including cancer vaccines and T-cell therapies, through his roles at Imyun Pharmaceuticals, Sakura Bio, and VaxilBio.
Biopharma Commercialization
As owner of a consultancy, he specializes in translating scientific concepts into commercially viable products through fundraising, strategic partnerships, and asset scouting.
+4 more topics Login to view topics
Career

Work history

6-2024
Co-Founder and CSO
Imyun Pharmaceuticals
10-2022 - 2-2026
Director
Sakura Bio
4-2022 - 6-2025
Director
Protica Bio
6-2019 - 11-2025
VP Innovation
VLX Ventures
1-2019 - 4-2025
Expert Manager
Catenion
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1995 - 1999
PhD
Weizmann Institute of Science
2006 - 2006
Executive Studies for CEOs
University of California, Irvine - The Paul Merage School of Business
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Lior. Free, 10 seconds.